Touchstone
Last syncNov 1, 2026, 6:55 PM ET

THC

Tenet Healthcare Corp Health Care Services-General Medical & Surgical Hospitals, NEC Russell 3000
$273.25Close $43.3BMarket cap $161.37 – $280.7752-week range Late-januaryNext report · estimated

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 84 · stronger than 84% of stocks over 12 months
  • Near its high 3% below its 52-week high

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 29, 2026
Off 12-month high 3%
1wk up 1.8% price change
1mo up 6.9% price change
12-month return up 31% market up 11% · its own up 20%
F-score — — Not assessed
Altman Z″ 2.24 Moderate risk
P/E 18.3× price / earnings
PEG — P/E / EPS growth
P/B 10.3× price / book
Earnings yield up 6.5% EBIT / enterprise value
Cheaper than 55% of the market · around average
Revenue growth up 3% year on year
EPS growth — latest quarter
Sales growth up 6% latest quarter · -0 pts
ROE up 56% return on equity
Free cash margin up 12% $2.5B FCF
D/E 3.14 long-term debt / equity
Net debt / EBITDA 2.4×
Interest cover —EBIT / interest

Trade setup

ATR% 3.2% $8.77 a day · 2×ATR $255.71
RS 84 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.6× vs 50-day average
Up/down volume 1.17 50 sessions
Implied move — no scheduled report
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Oct 29, 2026
Results reaction Oct 29, 2026+4% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $21.3B +3% on FY2024
$0 $25B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $17.6B FY2021 · $19.5B FY2022 · $19.2B FY2023 · $20.6B FY2024 · $20.7B FY2025 · $21.3B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $2.4B -42% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $768.0M FY2021 · $1.5B FY2022 · $1.0B FY2023 · $1.3B FY2024 · $4.1B FY2025 · $2.4B
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $2.5B +127% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $2.9B FY2021 · $910.0M FY2022 · $321.0M FY2023 · $1.6B FY2024 · $1.1B FY2025 · $2.5B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 11%
  • Free cash 12%
0% 20% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 4% · Free cash 16% FY2021 · Net 8% · Free cash 5% FY2022 · Net 5% · Free cash 2% FY2023 · Net 6% · Free cash 8% FY2024 · Net 20% · Free cash 5% FY2025 · Net 11% · Free cash 12%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $10.4B net debt
  • Cash
  • Long-term debt
$0 $20B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $2.4B · Long-term debt $15.9B FY2021 · Cash $2.4B · Long-term debt $15.8B FY2022 · Cash $858.0M · Long-term debt $15.2B FY2023 · Cash $1.2B · Long-term debt $15.1B FY2024 · Cash $3.0B · Long-term debt $13.3B FY2025 · Cash $2.9B · Long-term debt $13.3B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 158.61m +2.7% since FY2020
158.61m 154.41m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 154.41m FY2021 · 155.52m FY2022 · 156.46m FY2023 · 157.27m FY2024 · 158m FY2025 · 158.61m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $17.6B $19.5B $19.2B $20.6B $20.7B $21.3B
Operating income $2.0B $2.9B $2.3B $2.5B $6.0B $3.5B
Net income $768.0M $1.5B $1.0B $1.3B $4.1B $2.4B
Net margin 4% 8% 5% 6% 20% 11%
Earnings per share $7.23 $13.59 $9.06 $12.51 $41.52 $26.06
Free cash flow $2.9B $910.0M $321.0M $1.6B $1.1B $2.5B
Free cash margin 16% 5% 2% 8% 5% 12%
Cash $2.4B $2.4B $858.0M $1.2B $3.0B $2.9B
Long-term debt $15.9B $15.8B $15.2B $15.1B $13.3B $13.3B
Shareholders' equity $28.0M $1.0B $1.1B $1.6B $4.2B $4.2B
Shares outstanding 154.41m 155.52m 156.46m 157.27m 158m 158.61m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 29, 2026 Quarterly ↗ Sep 30, 2026 29d
Jul 29, 2026 Quarterly ↗ Jun 30, 2026 29d
Apr 30, 2026 Quarterly ↗ Mar 31, 2026 30d
Feb 17, 2026 Annual ↗ Dec 31, 2025 48d
Oct 28, 2025 Quarterly ↗ Sep 30, 2025 28d
Jul 30, 2025 Quarterly ↗ Jun 30, 2025 30d
Apr 29, 2025 Quarterly ↗ Mar 31, 2025 29d
Feb 18, 2025 Annual ↗ Dec 31, 2024 49d
Oct 29, 2024 Quarterly ↗ Sep 30, 2024 29d
Jul 30, 2024 Quarterly ↗ Jun 30, 2024 30d
Apr 30, 2024 Quarterly ↗ Mar 31, 2024 30d
Feb 16, 2024 Annual ↗ Dec 31, 2023 47d

Current reports

FiledDisclosed
Oct 29, 2026 Results ↗
Sep 22, 2026 Material agreement · New obligation ↗
Sep 8, 2026 Regulation FD · Other events ↗
Jul 23, 2026 Results ↗
May 29, 2026 Shareholder vote ↗
Apr 30, 2026 Results ↗
Apr 10, 2026 Director or officer change ↗
Mar 30, 2026 Director or officer change ↗
Feb 11, 2026 Results ↗
Feb 2, 2026 Results · Regulation FD · Other events ↗
Nov 24, 2025 Director or officer change ↗
Nov 18, 2025 Material agreement · New obligation ↗